Web8 de jun. de 2024 · /PRNewswire/ -- Onward Therapeutics (Onward) and Institut du Cancer de Montpellier (ICM) announced today the execution of an exclusive collaboration and... Web16 de fev. de 2024 · LAUSANNE, Switzerland, Feb. 16, 2024 /CNW/ -- Onward Therapeutics SA (Onward) announced today the execution of a worldwide exclusive license and co-development agreement with Biomunex ...
ONWARD Medical NV live - Euronext
Web13 de abr. de 2024 · JP Morgan op 7 sep 2024, hadden ze goed gezien en klopt nog steeds. [i]JP Morgan heeft het aandeel NN Group van zijn kooplijst gehaald, om diverse redenen, en verlaagde het koersdoel van 58,00 naar 47,00 euro. Dat bleek uit een rapport van de zakenbank. Laatste is van na de cijfers in feb. '23. maandag 20 februari 2024. Web17 de fev. de 2024 · Lausanne, Switzerland, February 17, 2024 – (PR Newswire) - Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in … somatogenic reproduction
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a …
Web12 de out. de 2024 · ONWARD Medical. Identification. Listing sponsor / Agent. Degroof Petercam SA/NV Symbol. ONWD ISIN code. NL0015000HT4 LEI code. 9845007A2CC4C8BFSB80 Exchange / Market. Euronext … WebOnward Therapeutics is a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough … We are a development stage oncology company, focusing on the identification … May 4th, 2024: Onward Therapeutics SA headquartered in Biopôle campus, … Armand is one of the three founders and CSO of Onward Therapeutics SA since … Onward Therapeutics SA (Onward), a global biotechnology company focused … Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS … Onward Therapeutics SA (Onward, we, us or our) is a company organized under … WebOncology Main sector Pharma Contact Route de la Corniche 4 1066 Epalinges / VD +41 22 566 57 70 [email protected] small business grant mn